awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q44166494-7CDE8B6D-8D41-41B9-B960-854471FCFF74
Q44166494-7CDE8B6D-8D41-41B9-B960-854471FCFF74
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44166494-7CDE8B6D-8D41-41B9-B960-854471FCFF74
Can mucosal healing be a cost-effective endpoint for biologic therapy in Crohn's disease? A decision analysis.
P2860
Q44166494-7CDE8B6D-8D41-41B9-B960-854471FCFF74
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44166494-7CDE8B6D-8D41-41B9-B960-854471FCFF74
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8aa9f253a5e3b8b176f7102eecb5deea188b609f
P2860
Long-term durability of infliximab treatment in Crohn's disease and efficacy of dose "escalation" in patients losing response.